ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

GE Healthcare clinical trials

Also known as GEHC.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 183 studies whose lead sponsor is GE Healthcare or one of 3 companies grouped under it. 22 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 5, 2026.

Our grouping of 4 registry names, not the registry’s. See them and correct one ↓

Compare GE Healthcare with Sino Biopharmaceutical and Bristol-Myers Squibb →

Pipeline: 3 programs

Each counted once: 3 with a study GE Healthcare leads registered in the last two years.

  • Phase 2
  • Phase 3

The 2 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of GE Healthcare’s own registered studies; GE Healthcare’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs GE Healthcare’s studies test, most open studies first — 18 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 8 more

Coming up

11 of GE Healthcare’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 6D
  3. J’27
  4. 2F
  5. 1M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. 1N

Add all 11 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 183 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now2212%Recruiting 17 · Not yet recruiting 3 · Enrolling by invitation 2
  • Under way, not recruiting21%
  • Completed11060%
  • Stopped early4122%Terminated 31 · Withdrawn 9 · Suspended 1
  • Status unknown or other84%Status unknown 7 · Approved for marketing 1

Phase

Where

  • United States117
  • Finland14
  • France12
  • Germany10
  • Canada8
  • United Kingdom8

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 1425
  20. 1126

By the year each study started; 18 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to GE Healthcare.

  • GE Healthcare
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    176 studies
  • Caption Health, Inc.
    Acquired — became part of GE Healthcare, Feb 17, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • U-Systems, Inc.
    Acquired — became part of GE Healthcare, Nov 9, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Nihon Medi-Physics Co., Ltd.
    Acquired — became part of GE Healthcare, Mar 31, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions GE Healthcare leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 183. Browse all 183 →